1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells.
(
- Contribution to journal › Article
-
Mark
Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047.
(
- Contribution to journal › Article
-
Mark
Apoptosis induced by the potential chemotherapeutic drug N1, N11-Diethylnorspermine in a neuroblastoma cell line.
(
- Contribution to journal › Article
- 2009
-
Mark
Normal-like breast cells, but not breast cancer cells, recovered from treatment with N ',N ''-diethylnorspermine
(
- Contribution to journal › Article
- 2008
-
Mark
Molecular mechanisms underlying N1, N11-diethylnorspermine-induced apoptosis in a human breast cancer cell line.
(
- Contribution to journal › Article
-
Mark
Different cell cycle kinetic effects of N1,N11-diethylnorspermine-induced polyamine depletion in four human breast cancer cell lines.
(
- Contribution to journal › Article
- 2007
-
Mark
Methotrexate concentrations in cerebrospinal fluid and serum, and the risk of central nervous system relapse in children with acute lymphoblastic leukaemia
(
- Contribution to journal › Article
- 2005
-
Mark
A novel mechanism of action of the fumagillin analog, TNP-470, in the B16F10 murine melanoma cell line
(
- Contribution to journal › Article
- 2003
-
Mark
Pharmacokinetics of doxorubicin and cisplatin used in intraoperative hyperthermic intrathoracic chemotherapy after cytoreductive surgery for malignant pleural mesothelioma and pleural thymoma
(
- Contribution to journal › Article
- 1999
-
Mark
Cisplatin at clinically relevant concentrations enhances interleukin-2 synthesis by human primary blood lymphocytes
(
- Contribution to journal › Article